Galmed Pharmaceuticals (EOCN) Current Assets (2013 - 2026)
Galmed Pharmaceuticals (EOCN) reported Current Assets of $11.71 million for Q2 2026, down 44.4% from $21.08 million a year earlier and down 26.9% from the prior quarter.
Powered by 
Analysis
Galmed Pharmaceuticals (EOCN) Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Galmed Pharmaceuticals posted Current Assets of $18.63 million.
- Current Assets has a five-year compound annual growth rate of -18.5% (FY2020 to FY2025).
- By year, Current Assets came in at $614,000 in FY2024 (-95.4%), $13.24 million in FY2023 (-10.1%), $14.72 million in FY2022 (-59.2%) and $36.05 million in FY2021 (-30.4%).
- The Q2 2026 figure ranks as the lowest quarterly Current Assets since Q4 2024.
- Year over year, Current Assets gained in four of the last seven quarters, with growth averaging 7.1%.
- The high point for year-over-year Current Assets in five years was Q1 2024 (growth of 840.5%); the low point was Q1 2023 (a decline of 96.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $16.03 million (Q1 2026), $18.63 million (Q4 2025) and $19.72 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Galmed Pharmaceuticals | 422,361.40 | 422,361.40 | - | 11.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.71 Mn |
| Mar 31, 2026 | 16.03 Mn |
| Dec 31, 2025 | 18.63 Mn |
| Sep 30, 2025 | 19.72 Mn |
| Jun 30, 2025 | 21.08 Mn |
| Mar 31, 2025 | 16.30 Mn |
| Dec 31, 2024 | 614,000.00 |
| Sep 30, 2024 | 17.69 Mn |
| Jun 30, 2024 | 10.08 Mn |
| Mar 31, 2024 | 11.18 Mn |
| Dec 31, 2023 | 13.24 Mn |
| Sep 30, 2023 | 14.20 Mn |
| Jun 30, 2023 | 9.79 Mn |
| Mar 31, 2023 | 1.19 Mn |
| Dec 31, 2022 | 14.72 Mn |
| Sep 30, 2022 | 20.48 Mn |
| Jun 30, 2022 | 23.13 Mn |
| Mar 31, 2022 | 29.70 Mn |
| Dec 31, 2021 | 36.05 Mn |
| Sep 30, 2021 | 43.69 Mn |
API Access
Galmed Pharmaceuticals Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=EOCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();